CardioGenics (OTCMKTS:CGNH) Stock Passes Above 200 Day Moving Average – Should You Sell?

CardioGenics Holdings Inc. (OTCMKTS:CGNH)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. CardioGenics shares last traded at $0.00, with a volume of 0 shares traded.

CardioGenics Price Performance

About CardioGenics

CardioGenics Holdings, Inc (OTCMKTS: CGNH) is a clinical diagnostics company specializing in the development, production and commercialization of immunoenzymatic assay kits and instruments for the detection and monitoring of cardiovascular disease. The company’s core focus lies in high-sensitivity cardiac biomarkers, which support early diagnosis of myocardial infarction, heart failure and related conditions. CardioGenics leverages proprietary antibody technology and assay platforms to deliver quantitative test results in clinical laboratory settings.

Headquartered in the United States, CardioGenics serves healthcare providers and diagnostic laboratories globally through a combination of direct sales channels and distribution partners.